Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer—a meta-analysis Jan HaussmannBálint TamaskovicsChristiane Matuschek Original Article 04 October 2019 Pages: 1041 - 1049
Outcome and management of rare high-grade “salivary” adenocarcinoma: the important role of adjuvant (chemo)radiotherapy Claudia ScherlMarlen HaderleinHeinrich Iro Original Article 26 July 2019 Pages: 1050 - 1059
Re-irradiation for osteoarthritis—retrospective analysis of 217 joints Matthias G. HautmannPhilipp RechnerChristoph Süß Original Article 25 July 2019 Pages: 1060 - 1067
Radiotherapy for painful benign skeletal disorders Nderim JunikuOliver MickeRalph Muecke Original Article Open access 27 August 2019 Pages: 1068 - 1073
Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy Tilman BostelRobert FörsterNils Henrik Nicolay Original Article Open access 25 June 2019 Pages: 1074 - 1085
Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated? Felix StegerMatthias G. HautmannCarsten Jungbauer Original Article 09 August 2019 Pages: 1086 - 1093
Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning Olaf WittensteinPatrick HiepeJuergen Dunst Original Article Open access 29 April 2019 Pages: 1094 - 1103
Successful integration of radiation oncology in preclinical medical education Michael OertelMartina SchmitzAnna Schober Original Article 15 July 2019 Pages: 1104 - 1109
Dosis-Deeskalation der adjuvanten Radiochemotherapie bei HPV-positiven Oropharynxkarzinomen: die MC1273-Phase-II-Studie Alexander RühleNils H. Nicolay Literatur kommentiert 14 October 2019 Pages: 1110 - 1112
Lokal konsolidierende Strahlentherapie beim oligometastasierten Nicht-kleinzelligen Bronchialkarzinom Alexander FabianFlorian PyschnyDavid Krug Literatur kommentiert 21 October 2019 Pages: 1113 - 1115
Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar I Ping JiangOliver BlanckJürgen Dunst Literatur kommentiert 30 October 2019 Pages: 1116 - 1118
Extreme Hypofraktionierung beim lokalisierten Prostatakarzinom. 5-Jahresergebnisse der HYPO-RT-PC-Studie: Kommentar II Gregor Goldner Literatur kommentiert 30 October 2019 Pages: 1119 - 1121